Banks Jerel A. has filed 4 insider transactions across 1 company since June 2023.
Most recent transaction: a grant/award of 450000 shares of Benitec Biopharma Inc. ($BNTC) on November 18, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 18, 2025 | Benitec Biopharma Inc. | $BNTC | Banks Jerel A. | Chief Executive Officer | A | Options (right to buy) | 450000 | $0.00 | 450,000.0000 | 37,254,839 | 9999.99% | 1.21% |
| Dec. 9, 2024 | Benitec Biopharma Inc. | $BNTC | Banks Jerel A. | Chief Executive Officer | A | Options (right to buy) | 2310000 | $0.00 | 2,310,000.0000 | 0 | 9999.99% | 0.00% |
| March 6, 2024 | Benitec Biopharma Inc. | $BNTC | Banks Jerel A. | Chief Executive Officer | A | Options (right to buy) | 466554 | $0.00 | 466,554.0000 | 0 | 9999.99% | 0.00% |
| June 13, 2023 | Benitec Biopharma Inc. | $BNTC | Banks Jerel A. | Chief Executive Officer | A | Options (right to buy) | 356900 | $0.00 | 356,900.0000 | 0 | 9999.99% | 0.00% |